Novanta is trading 4.58% lower at $128.96 in pre-market, with no confirmed catalyst for the decline. - No overnight company announcement or reported Q3 results were found to explain the move. - Novanta scheduled its Q3 release for after the market close on November 9, 2026. - Major U.S. indices were higher; investors may be awaiting earnings, but that link is unconfirmed.